Ed Weber
Papers
1
Total Citations
459
H-Index
1
About
Ed Weber is a leading figure in prostate cancer outcomes research, best known for his work in comparative effectiveness of radical therapies. His landmark 2012 study, "Comparative analysis of prostate‐specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy," has garnered over 459 citations, establishing a foundational framework for evaluating treatment success. Weber’s major contribution lies in systematically comparing prostate-specific antigen (PSA) free survival across risk-stratified patient groups, demonstrating that PSA is the most sensitive tool for measuring treatment effectiveness. This work directly addressed a critical gap: the lack of robust comparative data on radical therapy outcomes. By synthesizing results from the Prostate Cancer Results Study Group, Weber provided clinicians and patients with evidence-based benchmarks to guide treatment decisions. His research has had a profound impact on urological oncology, shaping how risk stratification informs therapeutic choices. Weber’s meticulous analysis continues to influence clinical guidelines and inspires ongoing investigations into personalized prostate cancer management, making his contributions indispensable to the field.
Research Focus
Key Achievements
Top Papers
- 1